Bioteknologi

Derfor stiger SLS-aktien før markedet åbner: SELLAS Life Sciences sætter REGAL fase 3-nedtælling tilbage i spil
···

Derfor stiger SLS-aktien før markedet åbner: SELLAS Life Sciences sætter REGAL fase 3-nedtælling tilbage i spil

SELLAS Life Sciences rose 3.4% to $4.29 in premarket trading Monday after closing at $4.15 Friday. The company is nearing the final analysis of its phase 3 AML trial, with 72 of 80 required events recorded as of late December. SELLAS reported $71.8 million in cash at year-end, plus $26.5 million from warrant exercises. Short interest stands at 41.33 million shares, or 24.42% of the float.
februar 23, 2026

Stock Market Today

  • Sole Bidder Secures $1.05M Beachside Apartment Amid Market Softening
    May 30, 2026, 3:30 AM EDT. A young couple became sole bidders on a two-bedroom beachside apartment in Bexley, Sydney, securing it for $1.05 million at auction. The property had a guide of $950,000 and a reserve of $1.1 million but sold below reserve amid a "reasonably tough" market, impacted by rising fuel prices and interest rates-a "triple threat" reducing buyer confidence, said auctioneer Clarence White. While first homebuyers are more active, banks are pulling pre-approvals, limiting spending power, according to PPD Real Estate's Nate Chacon. The auction saw only three registered bidders, down from expected five. This reflects broader softness as 924 properties are scheduled for auction this week in Sydney.

Latest Articles